Session 1B - Auditorium Adult cases - Adherence - Mental health - STIs - Opportunistic Infections - TB - Drug Interactions Panel discussion
|
|
|
- Owen Benson
- 5 years ago
- Views:
Transcription
1 CONFERENCE PROGRAMME WEDNESDAY, 24 OCTOBER h00 18h00 Registration OFFICIAL MEETING COMMENCES 14h00 15h30 Session 1A Adolescent cases - Teen pregnancy and breast feeding - Previously on PrEP, now pregnant. What to do? - Teen adherence Session 1B Adult cases - Adherence - Mental health - STIs - Opportunistic Infections - TB - Drug Interactions Panel discussion Session 1C Skills building - Nurse cases - Cases primary healthcare, rural doctors - Cases nurses - Panel discussion: Integration; Restarting 15h30 16h00 16h00 17h30 17h40 19h00 19h00 21h00 Session 2: Open Session Debate: Undetectable = Untransmittable - Yes - No Session 3: Opening Plenary Official conference opening Mechanism of resistance HIV drug resistance: are we about to win the war? Opening Cocktail Function Southern African HIV Clinicians Society Conference 2018 programme subject to change 2 P a g e
2 THURSDAY, 25 OCTOBER h30 08h15 Session 4 Stock outs and medicine availability - Stop Stockouts Project - Essential medicines to add to the formulary - TB 08h30 10h00 Session 5: Plenary Session How are we doing with HIV self-testing? - How are we doing with Universal test and treat? - How are we doing with retention and viral suppression? - How are we doing with prevention 10h00 10h30 10h30 12h00 12h00 13h30 Session 6A PrEP consult - How to administer PrEP: a typical clinical consultation - How to bill PrEP coding - The experience of a treating physician Lunch, exhibition and posters Session 6B Infant testing - Swallowing tablets - Paediatric third-line - The latest on infant testing, and how to access - Switching in children - Weight and age Session 6C Ethics and the Law - Whistle-blowing in the health-sector - Mandatory testing - Ethics on how health budgets are split - Q&A Satellite Session 7A GlaxoSmithKline session Southern African HIV Clinicians Society Conference 2018 programme subject to change 3 P a g e
3 13h30 15h00 Session 8A Cancer treatment models - Kaposi Sarcoma - Lymphoma - Role of pap smears in the HIV world - Update on cancer treatment Session 8B Resistance - Viral resistance first-line and second-line - At which detectable viral load should we switch? - Third-line treatment. Feedback on outcome of patients on national third-line regimen - Transmitted drug resistance: surveillance, implications, future Session 8C Prevention - Non-biomedical approaches - Condoms - Update on trials of vaccines and monoclonals in SA; how PrEP could augment these approaches - VMMC - Treatment as prevention - HIV prevention 2020 road map 15h00 15h30 15h30 17h00 Hall 5 Session 9A An update on - Integrase inhibitors - Protease Inhibitors - NRTIs - NNRTIs - Drug-drug interaction Session 9B What s coming / What s missing in paediatrics - Integrase inhibitors - Protease Inhibitors - Drug interactions Session 9C Modelling and scale-up - What are the numbers telling us - How the epidemic informs resource planning Cost effectiveness of TLD versus TEE 17h10 18h40 Session 10A Resistance - Third-line Session 10B Counselling - How to deliver HIV risk reduction counselling in 2018 Session 10C - Basic science Southern African HIV Clinicians Society Conference 2018 programme subject to change 4 P a g e
4 - Stanford database - how to interpret resistance test results - Integrating HIV prevention with other services 18h50 20h20 Session 11: Debate (Open Session) Hall 4 Implications of scarcer resources for 90:90:90 - Panel discussion FRIDAY, 26 OCTOBER h30 08h15 Southern African HIV Clinicians Society AGM 08h30 10h00 Session 12: Plenary Our current understanding of antibodies Why do we need cure How do you measure cure Management of patients with advanced HIV 10h00 10h30 10h30 12h00 Session 13A Opportunistic infections - An approach to intracranial mass lesions in HIV patients - Pneumocystis pneumonia - Endemic mycoses in HIV patients - An approach to chronic diarrhoea Session 13B HIV and TB in children and adults - Paediatric TB diagnosis and management - TB in children and HIV-TB coinfection - TB in adults and HIV-TB coinfection - TB and HIV co-infection including IRIS Session 13C Key populations and mobile populations - Injecting drug users in the region - Sex workers including satellite clinics; peer support - Engaging in care - Testing in taxi ranks Southern African HIV Clinicians Society Conference 2018 programme subject to change 5 P a g e
5 12h00 13h30 13h30 15h00 Lunch, exhibition and posters Session 15: Plenary Botswana DLT success Could good point-of-care testing revolutionise issues in the region? Balancing politicians, ministries of health, communities and donors Satellite Session 14B GILEAD session 15h00 15h30 15h30 17h00 Session 16A Skills building Clinical skills building Session 16B TB - Should the private sector be treating TB? Yes No Session 16C Update on PMTCT - Where are we with PMTCT, including epidemiology - Transmission of HIV in breastfeeding - Pregnant women on ART programmatic issues - Contraception, clinical issues, MPTs and new technologies 17h10 18h40 19h00 22h30 Session 17A DTG in pregnancy and breastfeeding - Safety - Efficacy Session 17B Technology Celebratory Dinner (RSVP only additional fee applies) Session 17C Ethics and research - The informed consent process - Payment of participants and of doctors - Q&A Southern African HIV Clinicians Society Conference 2018 programme subject to change 6 P a g e
6 SATURDAY, 27 OCTOBER h30 08h15 Session 18: Meet the Professor / Clinician How did I start my academic / research career? 08h30 10h00 Session 19: Plenary Vaccinations - HPV vaccines - Model for screening - Other vaccines - World of broadly neutralising antibodies - Pregnant women 10h00 10h30 10h30 12h00 12h00 13h30 - Society vaccination guidelines Session 20A Noncommunicable diseases - Inflammation - Hypertension - Obesity - Mental health - HIV and cardiology Lunch, exhibition and posters Session 20B Ethics and technology - Electronic medical records - Digital database and the PoPI act - Biobanks Session 20C Sexually transmitted infections - Strategy new strategy but what are the real implications - Hepatitis C - Update on vaginal microbiome and HIV - In context of PrEP - Management of STIs in HIV+ population case-based Satellite Session 21A Johnson & Johnson session Southern African HIV Clinicians Society Conference 2018 programme subject to change 7 P a g e
7 13h30 15h00 Session 22A Advanced HIV Management - Care of aging patients - Cryptococcal meningitis - Palliative care Session 22B Treatment optimisation Session 22C Best abstracts session Chair: Moeketsi Mathe 15h10 16h40 Session 23A Skills building Guidelines: all new Session 23B Adherence - Adherence - Adherence clubs - Role of viral load testing in adherence Session 23C Quality Improvement c/o the Aurum Institute 16h50 18h15 18h15 18h20 Session 24: Closing Plenary Big challenges in public health Big challenges in TB preventative therapy Big challenges in introducing and scaling up new prevention technologies Conference closing Moeketsi Mathe Southern African HIV Clinicians Society Conference 2018 programme subject to change 8 P a g e
versus CD4. PoC - Messaging - Specificity and - Ethics sensitivity of HIV - Feedback from diagnostic tests demonstration projects
PRE-CONFERENCE WORKSHOPS WEDNESDAY, 24 OCTOBER 2018 10h00 14h00 Pre-Conference Workshop Pre-Conference Workshop Pre-Conference Workshop Pre-Conference Workshop ITREMA trial feedback PrEP for the private
Southern African HIV Clinicians Society Conference 2018 programme subject to change 2 P a g e
CONFERENCE PROGRAMME WEDNESDAY, 24 OCTOBER 2018 08h00 18h00 Registration OFFICIAL MEETING COMMENCES 14h00 15h30 Session 1A Adolescent cases - Teen pregnancy and breast feeding - Previously on PrEP, now
Goal of this chapter. 6.1 Introduction Good practices for linkage to care General care for people living with HIV 84
Clinical guidelines across THE CONTINuUM OF CARE: LINKING PEOPLE DIAGNOSEd WiTH hiv infection to hiv care and treatment 06 6.1 Introduction 84 6.2 Good practices for linkage to care 84 6.3 General care
15h30 16h00. 16h00 17h30. 17h40 19h Southern African HIV Clinicians Society Conference 2018 programme subject to change 2 P a g e
CONFERENCE PROGRAMME WEDNESDAY, 24 OCTOBER 2018 08h00 18h00 Registration OFFICIAL MEETING COMMENCES 14h00 15h30 Session 1A Adolescent cases - Teen pregnancy and breast feeding (Julia Turner) - Previously
World Health Organization. A Sustainable Health Sector
World Health Organization A Sustainable Health Sector Response to HIV Global Health Sector Strategy for HIV/AIDS 2011-2015 (DRAFT OUTLINE FOR CONSULTATION) Version 2.1 15 July 2010 15 July 2010 1 GLOBAL
7 th FIDSSA CONFERENCE 2017 Programme as at 11 May 2017 PROVISIONAL ACADEMIC PROGRAMME
THURSDAY 9 NOVEMBER 15h00 17h00 Conference Registration FIDSSA Official Opening Ceremony 17h00 17h15 Welcome & Opening - Marc Mendelson (FIDSSA President) PLENARY SESSION 1: Emerging and Re-Emerging Infectious
PLANNING INTEGRATED HIV SERVICES AT THE HEALTH CENTRE
CHAPTER 2 PLANNING INTEGRATED HIV SERVICES AT THE HEALTH CENTRE 2.1 INTRODUCTION Achieving quality integrated HIV services at your health centre is dependant on good planning and management. This chapter
PROVIDING EXCELLENT PRIMARY CARE FOR PATIENTS LIVING WITH HIV
PROVIDING EXCELLENT PRIMARY CARE FOR PATIENTS LIVING WITH HIV Madhuri Lad, DO, FACOI, AAHIVS Clinical Assistant Professor OSU Department of Internal Medicine OBJECTIVES Demographics Definitions Diagnosis
EACS HIV Summer School PRELIMINARY PROGRAMME
EACS HIV Summer School Thursday, August 30, 2018 Monday, September 3, 2018 Montpellier, France This 5-day residential course is designed for clinicians experienced in HIV management who want an update
Management of HIV Infected Children and Adolescents: Public Sector Approach in Kenya
Management of HIV Infected Children and Adolescents: Public Sector Approach in Kenya KPA 2018 24-04-2018 Dr. Margaret Wainaina- Wafula Outline Introduction Evaluation of a child living with HIV. Standard
Prioritized research questions for adolescent HIV testing, treatment and service delivery
Prioritized research questions for adolescent HIV testing, treatment and service delivery The World Health Organization (WHO) and the Collaborative Initiative for Paediatric HIV Education and Research
Objectives. Outline. Section 1: Interaction between HIV and pregnancy. Effects of HIV on Pregnancy. Section 2: Mother-to-Child-Transmission (MTCT)
Objectives Prevention of Mother-to-Child Transmission (PMTCT) Teen Club Community Partners Training Programme By the end of the session participants will be able to: 1. Identify factors affecting the transmission
ACCELERATING HIV COMBINATION PREVENTION HIV COMBINATION PREVENTION INTERVENTIONS
ACCELERATING HIV COMBINATION PREVENTION HIV COMBINATION PREVENTION INTERVENTIONS Dr T Chidarikire HIV PREVENTION STRATEGIES 13 JUNE 2017 1 Purpose To share the Health Sector HIV Prevention Strategy with
IFMSA Policy Statement Ending AIDS by 2030
IFMSA Policy Statement Ending AIDS by 2030 Proposed by IFMSA Team of Officials Puebla, Mexico, August 2016 Summary IFMSA currently acknowledges the HIV epidemic as a major threat, which needs to be tackled
Updates on Revised Antiretroviral Treatment Guidelines Overview 27 March 2013
Updates on Revised Antiretroviral Treatment Guidelines 2013 Overview 27 March 2013 Introduction of Fixed Dose combination (FDC) FDCs will be available in facilities on 1 April 2013 The FDC ARV that will
HIV Drug Resistance (HIVDR)
Technical Guidance Note for Round 10 Global Fund HIV Proposals HIV Drug Resistance (HIVDR) Rationale for including HIVDR prevention and assessment in the proposal June 2010 As access to ART services expands,
Arizona State Office of Rural Health Webinar Series
Arizona State Office of Rural Health Webinar Series Mute your phone &/or computer microphone Time is reserved at the end for Q&A Please fill out the post-webinar survey Webinar is being recorded Recording
WHO HIV Drug Resistance Prevention and Assessment Strategy. Dr Richard Banda Technical Officer, HIV Drug Resistance WHO Inter-country Support Team
WHO HIV Drug Resistance Prevention and Assessment Strategy Dr Richard Banda Technical Officer, HIV Drug Resistance WHO Inter-country Support Team Eastern & Southern African Countries (ESA) 2 The HIV epidemic
Investing for Impact Prioritizing HIV Programs for GF Concept Notes. Lisa Nelson, WHO Iris Semini, UNAIDS
Investing for Impact Prioritizing HIV Programs for GF Concept Notes Lisa Nelson, WHO Iris Semini, UNAIDS Top 5 Lessons Learned 1 2 3 4 5 Prioritize within the allocation amount Separate above allocation
Session 1 Basic HIV Facts. Patient Navigation Intervention
Session 1 Basic HIV Facts Patient Navigation Intervention Session 1 HIV, the Viral Life Cycle & Understanding the Importance of HAART and Adherence https://www.aids.gov/hiv aids basics/just diagnosed with
Objectives. HIV in the Trenches HIV Update for the Primary Care Provider, An Overview The HIV Continuum of Care.
1:30 2:30pm HIV Update SPEAKER Gordon Dickinson, MD Presenter Disclosure Information The following relationships exist related to this presentation: Gordon Dickinson, MD, has no financial relationships
WHO WHO AIDS 2018 JOIN US AT
WHO AIDS 2018 JOIN US AT WHO at AIDS 2018 TEDROS GHEBREYESUS Director-General, WHO ZSUZSANNA JAKAB WHO Regional Director for Europe REN MINGHUI WHO Assistant Director-General for Communicable Diseases
HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012
HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012 Number of Cases Note: In this surveillance report, HIV cases include persons reported with HIV infection (non-aids), advanced HIV (non-aids) and AIDS within a
Evolving HIV Treatment Paradigms What we need to know
Evolving HIV Treatment Paradigms What we need to know Benjamin Young International Association of Providers of AIDS Care Washington, DC, USA Evolving HIV Treatment Paradigms When/who to treat Better medicines
The CQUIN Learning Network. Adolescents Living with HIV: Legal framework for testing, treatment, and transition, Challenges and Priorities: Uganda
The CQUIN Learning Network Adolescents Living with HIV: Legal framework for testing, treatment, and transition, Challenges and Priorities: Uganda Teddy N. Chimulwa STD/AIDS Control Program, Ministry of
PAEDIATRIC HIV INFECTION. Dr Ashendri Pillay Paediatric Infectious Diseases Specialist
PAEDIATRIC HIV INFECTION Dr Ashendri Pillay Paediatric Infectious Diseases Specialist Paediatric HIV Infection Epidemiology Immuno-pathogenesis Antiretroviral therapy Transmission Diagnostics Clinical
Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention
Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention Julia Walsh MD, MSc Professor School of Public Health University of California Berkeley Objectives Cost-effectiveness
Technical guidance for Round 9 Global Fund HIV proposals
Technical guidance for Round 9 Global Fund HIV proposals Broad Area Service Delivery Area TREATMENT Prevention and assessment of HIV drug resistance (HIVDR) This technical brief provides key information
THE ROLE OF THE SOUTH AFRICAN SOCIETY OF PHYSIOTHERAPY IN SUPPORT OF THE NATIONAL HIV & AIDS AND STI STRATEGIC PLAN FOR SOUTH AFRICA
THE ROLE OF THE SOUTH AFRICAN SOCIETY OF PHYSIOTHERAPY IN SUPPORT OF THE NATIONAL HIV & AIDS AND STI STRATEGIC PLAN FOR SOUTH AFRICA 2012-2016 South African Society of Physiotherapy P.O. Box 752378 Gardenview
Review of the Democratic Republic of the Congo (DRC) by the Committee on the Elimination of Discrimination Against Women (CEDAW)
Review of the Democratic Republic of the Congo (DRC) by the Committee on the Elimination of Discrimination Against Women (CEDAW) Submission: Elizabeth Glaser Pediatric AIDS Foundation June 2013 Introduction:
HIV Treatment as Prevention (TasP)
HIV Treatment as Prevention (TasP) Last updated: April 3, 2019 Together, we can change the course of the HIV epidemic one woman at a time. #onewomanatatime #thewellproject What Is Treatment as Prevention?
Biomedical Prevention Update Thomas C. Quinn, M.D.
Biomedical Prevention Update Thomas C. Quinn, M.D. Associate Director of International Research National Institute of Allergy and Infectious Diseases Director, Johns Hopkins Center for Global Health Global
HIV Epidemic in India
HIV Epidemic in India Dr.R.R.Gangakhedkar Head, Division of Epidemiology & Communicable Diseases, Indian Council of Medical Research New Delhi Waves in Spread of HIV Epidemic Core Group Bridge Populationmostly
World Health Organization Strategy for HIV Drug Resistance Surveillance in Low- and Middle- Income Countries
World Health Organization Strategy for HIV Drug Resistance Surveillance in Low- and Middle- Income Countries Silvia Bertagnolio, MD World Health Organization, Geneva Lusaka, 6 May 2014 Key characteristics
HIV AND INFANT FEEDING
HIV AND INFANT FEEDING UPDATED WHO GUIDELINES, 2016 Nigel Rollins Maternal, Newborn, Child and Adolescent Health WHO guidelines http://www.who.int/hiv/en/ Setting national recommendations for infant feeding
Adapting Treatment 2.0 in Viet Nam - Toward Universal and Sustainable Access -
Adapting Treatment 2.0 in Viet Nam - Toward Universal and Sustainable Access - Associate Professor, Bui Duc Duong, MD, Ph.D. Deputy Director General, Ministry of Health Socialist Republic of Viet Nam HIV
UNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision
UNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision Updated version following MERG recommendations Context In light of country reports, regional workshops and comments received by a
Treat All : From Policy to Action - What will it take?
Strategy Finance Integration Cascade of services People centred Political Will Treat All : From Policy to Action - What will it take? Thursday, 9 June, 13.00 14.30 Conference Room 11, United Nations Questions
Towards universal access
Key messages Towards universal access Scaling up priority HIV/AIDS interventions in the health sector September 2009 Progress report Towards universal access provides a comprehensive global update on progress
Differentiated Care Improving Engagement and Retention in HIV Care. Meg Doherty, MD PhD MPH World Health Organization
Differentiated Care Improving Engagement and Retention in HIV Care Meg Doherty, MD PhD MPH World Health Organization Why differentiated care and how can it facilitate epidemic control Effects on linkage,
INTERNAL QUESTIONS AND ANSWERS DRAFT
WHO CONSOLIDATED GUIDELINES ON THE USE OF ANTIRETROVIRAL DRUGS FOR TREATING AND PREVENTING HIV INFECTION Background: INTERNAL QUESTIONS AND ANSWERS DRAFT At the end of 2012, 9.7 million people were receiving
HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS
POLICY BRIEF HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS CONSOLIDATED GUIDELINES JULY 2014 Policy brief: Consolidated guidelines on HIV prevention, diagnosis, treatment and care for
Obstetrics and HIV An Update. Jennifer Van Horn MD University of Utah
Obstetrics and HIV An Update Jennifer Van Horn MD University of Utah Obstetrics and HIV Perinatal transmission Testing Antiretroviral therapy Antepartum management Intrapartum management Postpartum management
Integrating prevention & management of STI/HIV/AIDS into reproductive, maternal and newborn health services in China
Integrating prevention & management of STI/HIV/AIDS into reproductive, maternal and newborn health services in China China presentation Wang Linhong MD, Professor National Center of MCH, China CDC 1 HIV/AIDS
HIV Testing. Susan Tusher, LMSW Program Coordinator The Kansas AIDS Education and Training Center
HIV Testing Susan Tusher, LMSW Program Coordinator The Kansas AIDS Education and Training Center The Number of Persons in the US Living with HIV Continues to Increase Over 1 Million people are estimated
Diagnosing HIV/AIDS. Marissa Humphrey MSIV New York Medical College GE/NMF Scholar
Diagnosing HIV/AIDS Marissa Humphrey MSIV New York Medical College GE/NMF Scholar Introduction The World Health Organization estimates that 7 percent of all AIDS cases have occurred in Africa and the highest
THE POWER OF UNDETECTABLE. What you need to know about HIV treatment as prevention
THE POWER OF UNDETECTABLE What you need to know about HIV treatment as prevention CONTENTS 3 Treatment as prevention First, a few basics: What is an undetectable viral load? How do I know if I m undetectable?
VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology
VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology HIV stands for human immunodeficiency virus. If left untreated, HIV can lead to the disease AIDS (acquired immunodeficiency syndrome).
Multiple choice questions: ANSWERS
Multiple choice questions: ANSWERS Chapter 1. Diagnosis and promotion of serostatus awareness in sub-saharan Africa 1. Antiretroviral therapy reduces HIV transmission from a HIV- positive person to a susceptible
HIV DRUG RESISTANCE AND STEWARDSHIP 3 RD LINE PROGRAMME
HIV DRUG RESISTANCE AND STEWARDSHIP 3 RD LINE PROGRAMME SOUTHERN AFRICAN HIV CLINICIANS SOCIETY CONFERENCE - 2014 26 SEPTEMBER 2014 Khadija Jamaloodien Affordable Medicines ANTIMICROBIAL STEWARDSHIP The
UPDATE ON THE CLINICAL MANAGEMENT OF HIV IN BARBADOS
UPDATE ON THE CLINICAL MANAGEMENT OF HIV IN BARBADOS 82 nd UWI/ BAMP CME November 18th and 19th, 2017 Tiffany Jordan, MB BS Locum Clinical Medical Officer, Ladymeade Reference Unit OBJECTIVES 1. Epidemiology
South Africa s National HIV Programme. Dr Zuki Pinini HIV and AIDS and STIs Cluster NDOH. 23 October 2018
South Africa s National HIV Programme Dr Zuki Pinini HIV and AIDS and STIs Cluster NDOH 23 October 2018 Overview The HIV and AIDS sub-programme at NDOH is responsible for: policy formulation, coordination,
Impact of ART resistance in sub Saharan Africa
Impact of ART resistance in sub Saharan Africa Elliot Raizes, MD Division of Global HIV/TB US Centers for Disease Control and Prevention ITREMA Resistance Training Workshop 24 October, 2018 Center for
Clinical Management Guidelines 2012
Central American Course Monitoring and Evaluation for HIV/AIDS Policy and Program Management 1 2 3 4 Module 1 Unit 1 Clinical Management Guidelines 2012 National TB, HIV/AIDS & other STIs Programme Ministry
INTEGRATING HIV INTO PRIMARY CARE
INTEGRATING HIV INTO PRIMARY CARE ADELERO ADEBAJO, MD, MPH, AAHIVS, FACP NO DISCLOSURE 1.2 million people in the United States are living with HIV infection and 1 in 5 are unaware of their infection.
GLOBAL AIDS MONITORING REPORT
KINGDOM OF SAUDI ARABIA MINISTRY OF HEALTH GLOBAL AIDS MONITORING REPORT COUNTRY PROGRESS REPORT 2017 KINGDOM OF SAUDI ARABIA Submission date: March 29, 2018 1 Overview The Global AIDS Monitoring 2017
HIV Drug Resistance. Together, we can change the course of the HIV epidemic one woman at a time.
HIV Drug Resistance Together, we can change the course of the HIV epidemic one woman at a time. #onewomanatatime #thewellproject What Is Resistance? HIV drugs are designed to keep the amount of HIV virus
TasP and PrEP- Wishful thinking in the developing world?
TasP and PrEP- Wishful thinking in the developing world? Professor Helen Rees Executive Director, WRHI, Wits Reproductive Health and HIV Institute & Ad Hominem Professor, Department of Ob/Gyn, University
Practice Transformation Project Provider Assessment (PT-PA)
Practice Transformation Project Provider Assessment (PT-PA) Instructions: The goal of this assessment is to describe current skills and services delivered by staff/providers participating in the PT activities
Annex A: Impact, Outcome and Coverage Indicators (including Glossary of Terms)
IMPACT INDICATORS (INDICATORS PER GOAL) HIV/AIDS TUBERCULOSIS MALARIA Reduced HIV prevalence among sexually active population Reduced HIV prevalence in specific groups (sex workers, clients of sex workers,
WESTERN CAPE ART GUIDELINES PRESENTATION 2013
WESTERN CAPE ART GUIDELINES PRESENTATION 2013 The WC guidelines are based on SA National ART guidelines dated 24th March 2013 Acknowledgement goes to members of the Adult and Paediatric HAST policy advisory
Pregnancies amongst adolescents and young women 16% of all births - 19% will have repeat pregnancies before age 20
Introduction Pregnancies amongst adolescents and young women 16% of all births - 19% will have repeat pregnancies before age 20 Proportions HIV infections 19% amongst adolescents (- 29.5% nationally 15
NYS PrEP Programming. Lyn Stevens, NP, MS, ACRN Office of the Medical Director, AIDS Institute PrEP Monitoring in NYC and NYS February 19, 2016
NYS PrEP Programming March 21, 2016 Lyn Stevens, NP, MS, ACRN Office of the Medical Director, AIDS Institute PrEP Monitoring in NYC and NYS February 19, 2016 March 21, 2016 2 New York State Priorities
Essential minimum package ALHIV service provision: Community level
Essential minimum package service provision: Community level Partner or Actor COMMUNITY HEALTH WORKERS (CHWs) Minimum components Key Activities Key Accountable Provide communitybased HCT Support treatment
Guidelines for Implementing Pre-Exposure Prophylaxis For The Prevention of HIV in Youth Peter Havens, MD MS Draft:
Guidelines for Implementing Pre-Exposure Prophylaxis For The Prevention of HIV in Youth Peter Havens, MD MS Draft: 10-2-2015 Clinical studies demonstrate that when a person without HIV infection takes
Page 1. Outline. Outline. Building specialized knowledge: HIV. Biological interactions. Social aspects of the epidemic. Programmatic actions
Harvard-Brazil Collaborative Public Health Field Course January 2014 Lecture # 8 Building specialized knowledge: HIV Aluisio Segurado Department of Infectious Diseases School of Medicine, University of
Day Seven: Helping HIV Affected Children and Orphans
Note: This training material is continually being evaluated and updated to reflect current needs and best practices therefore it should be viewed as work in progress. Any person, organization, or institution
In the Caribbean, the rate of new HIV infections, concentrated among key population, remained stable ART 8
Background 10,711,067 1 In the Caribbean, the rate of new infections, concentrated among key population, remained stable Coinfections 2010-2015 2 Co-management of Number of people living with 3 prevalence
AETC INTERPROFESSIONAL EDUCATION FACULTY BASELINE ASSESSMENT
AETC INTERPROFESSIONAL EDUCATION FACULTY BASELINE ASSESSMENT INSTRUCTIONS: Assessment is to be completed by faculty members participating or interested in participating in the AETC HIV IPE project, including
Technical Guidance Note for Global Fund HIV Proposals. TREATMENT - Antiretroviral Treatment-infants, children and adults
Technical Guidance Note for Global Fund HIV Proposals TREATMENT - Antiretroviral Treatment-infants, children and adults May 2010 This technical brief is designed to provide key technical information to
IAS Conference Vienna 18 th to 23 rd July 2010 overview. Paul Clift King s College Hospital/UK-CAB
IAS Conference Vienna 18 th to 23 rd July 2010 overview Paul Clift King s College Hospital/UK-CAB Overall Conference I c. 25,000 participants Covers everything HIV-related Several Pre-conferences: Faith,
THE SOUTH AFRICAN ANTIRETROVIRAL TREATMENT GUIDELINES 2010
THE SOUTH AFRICAN ANTIRETROVIRAL TREATMENT GUIDELINES 2010 The South African Antiretroviral Treatment Guidelines 2010 Goals of the programme Achieve best health outcomes in the most cost-efficient manner
Reviewing Sexual Health and HIV NM2715
Reviewing Sexual Health and HIV NM2715 Learning objectives To observe and learn from a case study. What happens to a couple who attend a GUM clinic, for screening and subsequent treatment? Revision of
Objectives. Types of HIV Tests. Age Appropriateness of Tests. Breastfeeding and HIV Testing. Why are there different tests for different ages?
Objectives At the end of the lesson participants will be able to: Identify the types of HIV tests available in Botswana State who should be tested Identify which tests are used for infants and children
Sex Work in Sub-Saharan Africa : Opportunities and Challenges
Sex Work in Sub-Saharan Africa : Opportunities and Challenges Dr Traore Isidore May 26, 2016 Definition of Sex Worker Female, male and transgender adults (18 years of age and above) who receive money or
Anti Retroviral Traitment (ARVs)
Anti Retroviral Traitment (ARVs) IEC material for People With Disabilities UPHLS - 2015 - Anti Retroviral Traitment Booklet Produced by AZ MEDIA No part of this publication may be reproduced without prior
Living Positively with HIV
Living Positively with HIV Pregnancy and Planning a Family How do I avoid pregnancy and STI? What is this booklet for? This booklet gives basic information about planning a family if you are living with
On the Horizon for Consideration: Biomedical Advances in HIV Prevention
On the Horizon for Consideration: Biomedical Advances in HIV Prevention Francisco Ruiz, MS Senior Manager, National Alliance of State and Territorial AIDS Directors New Jersey Governor's Advisory Council
TRANSITION TO NEW ANTIRETROVIRALS IN HIV PROGRAMMES
POLICY BRIEF HIV TREATMENT TRANSITION TO NEW ANTIRETROVIRALS IN HIV PROGRAMMES JULY 2017 WHO This policy brief provides advice on a phased approach to transitioning to new WHO-recommended HIV treatment
ARV Consolidated Guidelines 2015
ARV Consolidated Guidelines 2015 This document outlines the draft list of PICO questions to support systematic review process for the 2015 ARV guidelines process. PICO questions are grouped by clinical
Scaling up priority HIV/AIDS interventions in the health sector
TOWARDS UNIVERSAL ACCESS? Scaling up priority HIV/AIDS interventions in the health sector Yves Souteyrand, WHO October 2011 Towards universal access targets UN General Assembly High level Meeting June
10/17/2015. Chapter 55. Care of the Patient with HIV/AIDS. History of HIV. HIV Modes of Transmission
Chapter 55 Care of the Patient with HIV/AIDS All items and derived items 2015, 2011, 2006 by Mosby, Inc., an imprint of Elsevier Inc. All rights reserved. History of HIV Remains somewhat obscure The earlier
INTRODUCTION TIMELINE: PrEP IMPLEMENTATION SA POLICY & GUIDELINES FACILITY AUDIT TOOL IEC MATERIALS MONITORING & EVALUATION
INTRODUCTION TIMELINE: PrEP IMPLEMENTATION SA POLICY & GUIDELINES WHO guidelines [EXECUTIVE SUMMARY] NDoH PrEP policy [FULL] NDoH PrEP guidelines [FULL] FACILITY AUDIT TOOL IEC MATERIALS MONITORING & EVALUATION
INTRODUCTION AND GUIDING PRINCIPLES
CHAPTER 1 INTRODUCTION AND GUIDING PRINCIPLES The Operations Manual is intended for use in countries with high HIV prevalence and provides operational guidance on delivering HIV services at health centres.
BASIC HEALTH CARE SERVICES Community Health Free Clinic
BASIC HEALTH CARE SERVICES Community Health Free Clinic 947 14 th Ave SE Cedar Rapids, IA 52401 www.communityhfc.org 363-0416 Monday 8:00 AM to 5:30 PM Tuesday 8:00 AM to 12:00 PM Clinic Hours: Mon: 8:00
The new German strategy on HIV, Hepatitis B, C and STI, an integrated approach. Ines Perea Ministry of Health, Germany
The new German strategy on HIV, Hepatitis B, C and STI, an integrated approach Ines Perea Ministry of Health, Germany Reasons for a new strategy in 2016 New international agreements (SDG s) Renewed political
High Impact Prevention: Science, Practice, and the Future of HIV
High Impact Prevention: Science, Practice, and the Future of HIV Jonathan Mermin, MD, MPH National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers for Disease Control and Prevention
Strengthening the Evidence for HIV Investments: Allocative Efficiency of HIV Responses: Results and Experiences
Strengthening the Evidence for HIV Investments: Allocative Efficiency of HIV Responses: Results and Experiences Presentation by: Dr Maxim Berdnikov, Global Fund Importance of Evidence of Impact under the
WHO recommendations for HIVDR surveillance and their application in Latin America and the Caribbean
WHO recommendations for HIVDR surveillance and their application in Latin America and the Caribbean Giovanni Ravasi Pan-American Health Organization, Brazil ravasigi@paho.org Regional Consultation on HIV
Consultation on WHO ART Guidelines
Consultation on WHO ART Guidelines Defining Standards of Treatment and Care ICAAP9, Bali, Indonesia Global Network of People Living with HIV Asia Pacific Network of People Living with HIV August 2009 Introduction
Immediate Offer of HIV Treatment: How To Deliver on the Second 90 (including Supply Chain Management and Drug Stockouts)
Immediate Offer of HIV Treatment: How To Deliver on the Second 90 (including Supply Chain Management and Drug Stockouts) Roselyne TOBY,MD, ID specialist Infectious Disease Unit/Yaounde Central Hospital
TB/HIV Monitoring & Advocacy Project Interview Tool
TB/HIV Monitoring & Advocacy Project Interview Tool This interview tool is based upon the Interim Policy on Collaborative TB/HIV Activities of the World Health Organization. 1 It is designed to help you
PRECONCEPTION COUNSELING
PRECONCEPTION COUNSELING A Counseling Guide for Healthcare Providers Preconception Care & Counseling 1 Introduction Pregnancy planning and preconception care are important in order to: 1. Ensure maternal
World Food Programme (WFP)
UNAIDS 2016 REPORT World Food Programme (WFP) Unified Budget Results and Accountability Framework (UBRAF) 2016-2021 2 Contents Achievements 2 Introduction 2 Innovative testing strategies 2 Access to treatment
Botswana Advocacy paper on Resource Mobilisation for HIV and AIDS
Republic of Botswana Botswana Advocacy paper on Resource Mobilisation for HIV and AIDS Page 1 June 2012 1.0 Background HIV and AIDS remains one of the critical human development challenges in Botswana.
Aligning UNICEF s HIV Vision to the SDGs and UNAIDS Strategy. Dr. Chewe Luo Chief, HIV/AIDS Section UNICEF NYHQ 5 April 2016
Aligning UNICEF s HIV Vision to the SDGs and UNAIDS Strategy Dr. Chewe Luo Chief, HIV/AIDS Section UNICEF NYHQ 5 April 2016 An Unfinished Agenda: HIV/AIDS among Children & Adolescents Trends & projections
increased efficiency. 27, 20
Table S1. Summary of the evidence on the determinants of costs and efficiency in economies of scale (n=40) a. ECONOMETRIC STUDIES (n=9) Antiretroviral therapy (n=2) Scale was found to explain 48.4% of
BUDGET AND RESOURCE ALLOCATION MATRIX
Strategic Direction/Function ILO Strengthened capacity of young people, youth-led organizations, key service providers and partners to develop, implement, monitor and evaluate HIV prevention programmes
Elements of Reproductive Health
SEXUAL& REPRODUCTIVE HEALTH and HIV/AIDS INTEGRATION: Issues for consideration Dr. Chris Baryomunsi, MP Parliament of Uganda Elements of Reproductive Health Safe motherhood Family Planning Prevention and